Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | CTSL | P07711 | 1/20 | 0.40 |
| ▸ | FKBP1A | P62942 | 5/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CASP1 | P29466 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | SYK | P43405 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.37 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7104042 | 1.00 | TSHR (0.46) | TSHRCYP1A2CYP2C9CYP2C19CTSL | |
| SCHEMBL7223220 | 1.00 | TSHR (0.46) | TSHRCYP1A2CYP2C9CYP2C19CTSL | |
| SCHEMBL7103660 | 0.85 | TSHR (0.51) | TSHRCYP1A2CYP2C9CYP2C19FKBP1A | |
| SCHEMBL7222846 | 0.85 | TSHR (0.51) | TSHRCYP1A2CYP2C9CYP2C19FKBP1A | |
| SCHEMBL7220762 | 0.85 | TSHR (0.51) | TSHRCYP1A2CYP2C9CYP2C19FKBP1A | |
| SCHEMBL7098588 | 0.81 | TSHR (0.53) | TSHRCYP1A2CYP2C9CYP2C19CTSL | |
| SCHEMBL7098587 | 0.81 | TSHR (0.53) | TSHRCYP1A2CYP2C9CYP2C19CTSL | |
| SCHEMBL24410821 | 0.77 | TSHR (0.49) | TSHRCYP2C9CYP2C19FKBP1AALDH1A1 | |
| SCHEMBL964516 | 0.77 | CASP1 (0.44) | TSHRCTSLFKBP1AALDH1A1CYP3A4 | |
| SCHEMBL964514 | 0.77 | CASP1 (0.44) | TSHRCTSLFKBP1AALDH1A1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6596752-B1 | Small molecules that are potent inhibitors of alpha 4 beta 1 mediated adhesion to either VCAM or CS-1 and which could be useful for the treatment of inflammatory diseases. | TANABE SEIYAKU CO., LTD. (JP) | 2003-07-22 | — | — | US | disclosed |
| US-20030130349-A1 | Inhibitors of alpha 4beta1 mediated cell adhesion | TANABE SEIYAKU CO., LTD. | 2003-07-10 | — | — | US | disclosed |
| US-6482849-B1 | Inhibitors of α4β1 mediated cell adhesion | TANABE SEIYAKU CO., LTD. (JP) | 2002-11-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030130349-A1 | Inhibitors of alpha 4beta1 mediated cell adhesion | VCAM1, ICAM1, ITGB1 | TSHR 4066/4885CYP1A2 1888/4885CYP2C9 3367/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.